[go: up one dir, main page]

EA200000389A3 - Новые замещенные пиридины или пиперидины, способ их получения и содержащие их фармацевтические композиции - Google Patents

Новые замещенные пиридины или пиперидины, способ их получения и содержащие их фармацевтические композиции

Info

Publication number
EA200000389A3
EA200000389A3 EA200000389A EA200000389A EA200000389A3 EA 200000389 A3 EA200000389 A3 EA 200000389A3 EA 200000389 A EA200000389 A EA 200000389A EA 200000389 A EA200000389 A EA 200000389A EA 200000389 A3 EA200000389 A3 EA 200000389A3
Authority
EA
Eurasian Patent Office
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
substituted pyridine
piperidine compounds
Prior art date
Application number
EA200000389A
Other languages
English (en)
Other versions
EA003053B1 (ru
EA200000389A2 (ru
Inventor
Отто Мет-Кон
Чу-Йи Ю
Пьер Лестаж
Мари-Сесиль Лебрэн
Даниель-Анри Кеньяр
Пьер Ренар
Original Assignee
Адир Э Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Адир Э Компани filed Critical Адир Э Компани
Publication of EA200000389A2 publication Critical patent/EA200000389A2/ru
Publication of EA200000389A3 publication Critical patent/EA200000389A3/ru
Publication of EA003053B1 publication Critical patent/EA003053B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

(57) Изобретение относится к соединениям формулы (I)где А означает пиридиновую, пиридиниевую или пиперидиновую группу;R, R, Rи Rопределены как указано в описании;Rозначает атом водорода, азотсодержащий гетероцикл или группу формулы (II)Rозначает атом водорода или линейный или разветвленный (C-С)-алкил.Изобретение также относится к лекарственным средствам.
EA200000389A 1999-05-05 2000-05-04 Новые замещенные пиридины или пиперидины, способ их получения и содержащие их фармацевтические композиции EA003053B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9905690A FR2793245B1 (fr) 1999-05-05 1999-05-05 Nouveaux composes pyridiniques ou piperidiniques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (3)

Publication Number Publication Date
EA200000389A2 EA200000389A2 (ru) 2000-12-25
EA200000389A3 true EA200000389A3 (ru) 2001-02-26
EA003053B1 EA003053B1 (ru) 2002-12-26

Family

ID=9545222

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000389A EA003053B1 (ru) 1999-05-05 2000-05-04 Новые замещенные пиридины или пиперидины, способ их получения и содержащие их фармацевтические композиции

Country Status (22)

Country Link
US (6) US6323220B1 (ru)
EP (1) EP1050531B1 (ru)
JP (2) JP3533361B2 (ru)
KR (1) KR100472519B1 (ru)
CN (1) CN100371326C (ru)
AT (1) ATE282595T1 (ru)
AU (1) AU764388B2 (ru)
BR (1) BR0002287A (ru)
CA (1) CA2308867C (ru)
DE (1) DE60015844T2 (ru)
DK (1) DK1050531T3 (ru)
EA (1) EA003053B1 (ru)
ES (1) ES2233302T3 (ru)
FR (1) FR2793245B1 (ru)
HU (1) HUP0001789A3 (ru)
MX (1) MXPA00004343A (ru)
NO (1) NO317095B1 (ru)
NZ (1) NZ504338A (ru)
PL (1) PL197661B1 (ru)
PT (1) PT1050531E (ru)
SI (1) SI1050531T1 (ru)
ZA (1) ZA200002207B (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7687513B1 (en) 2004-10-21 2010-03-30 University Of Notre Dame Du Lac Aminopyridinium ionic liquids
US7812098B2 (en) * 2006-03-31 2010-10-12 Depuy Products, Inc. Bearing material of medical implant having reduced wear rate and method for reducing wear rate
FR2905009A1 (fr) * 2006-08-18 2008-02-22 Servier Lab Methode de criblage de composes aux proprietes anti-amyloide
WO2009059260A1 (en) * 2007-11-02 2009-05-07 Yaupon Therapeutics, Inc. Use of lobeline epimers in the treatment of central nervous system diseases, pathologies, and drug abuse
WO2009061906A2 (en) * 2007-11-06 2009-05-14 Mayo Foundation For Medical Education And Research Treating protein misfolding diseases
EP2186419A1 (en) * 2008-11-13 2010-05-19 Tchibo GmbH NMP-containing extract, a method of its production and uses thereof
JPWO2010087315A1 (ja) * 2009-01-29 2012-08-02 株式会社林原生物化学研究所 抗アルツハイマー病剤
JP5591720B2 (ja) * 2009-01-29 2014-09-17 株式会社林原 抗神経変性疾患剤
WO2010087313A1 (ja) * 2009-01-29 2010-08-05 株式会社林原生物化学研究所 神経突起伸展促進剤
JP7319395B2 (ja) * 2019-06-14 2023-08-01 ディスアーム セラピューティクス， インコーポレイテッド Ｓａｒｍ１の阻害剤

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3840523A (en) * 1973-04-25 1974-10-08 Richardson Merrell Inc Tricyclic arylalkylene lactamimides
US4082806A (en) 1975-12-18 1978-04-04 Wright State University Preparation of tetraketones
JPS5328177A (en) * 1976-08-25 1978-03-16 Teijin Ltd Optical active piperidine derivatives and their preparation
ES2052059T3 (es) * 1988-03-16 1994-07-01 Ciba Geigy Ag Procedimiento para la obtencion de tiocompuestos.
EP0346791B1 (en) * 1988-06-14 1994-04-06 G.D. Searle & Co. 1,2-diarylethylamines for treatment of neurotoxic injury
JP2522690B2 (ja) 1988-06-16 1996-08-07 富士写真フイルム株式会社 ハロゲン化銀カラ―写真感光材料
US5414005A (en) * 1993-10-28 1995-05-09 Dynagen, Inc. Methods and articles of manufacture for the treatment of nicotine withdrawal and as an aid in smoking cessation
GB9304919D0 (en) * 1993-03-10 1993-04-28 Celltech Ltd Chemical compounds
FR2756826B1 (fr) * 1996-12-05 1999-01-08 Adir Nouveaux derives tetrahydropyridiniques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US5830904A (en) * 1997-02-05 1998-11-03 University Of Kentucky Research Foundation Lobeline compounds as a treatment for psychostimulant abuse and withdrawal, and for eating disorders
US6087376A (en) * 1997-02-05 2000-07-11 University Of Kentucky Research Foundation Use of lobeline compounds in the treatment of central nervous system diseases and pathologies
AU5977598A (en) * 1997-02-07 1998-08-26 Synapse Pharmaceutical International, Inc. Pharmaceutical composition for treatment of synaptic dysfunction comprising an oxime
JPH10287634A (ja) * 1997-04-11 1998-10-27 Otsuka Pharmaceut Co Ltd ベンゼン誘導体
TW544448B (en) * 1997-07-11 2003-08-01 Novartis Ag Pyridine derivatives
PT915088E (pt) * 1997-10-31 2003-01-31 Hoffmann La Roche Derivados de d-prolina
US6015824A (en) * 1998-02-10 2000-01-18 Hoffmann-La Roche Ag Pyrrolidine and piperidine derivatives and treatment of neurodegenerative disorders

Also Published As

Publication number Publication date
US20020040036A1 (en) 2002-04-04
ATE282595T1 (de) 2004-12-15
US20030181484A1 (en) 2003-09-25
US6734196B2 (en) 2004-05-11
FR2793245B1 (fr) 2002-10-11
US6323220B1 (en) 2001-11-27
NO20002351L (no) 2000-11-06
FR2793245A1 (fr) 2000-11-10
AU3255200A (en) 2000-11-09
SI1050531T1 (en) 2005-04-30
EA003053B1 (ru) 2002-12-26
ES2233302T3 (es) 2005-06-16
CN1277192A (zh) 2000-12-20
JP2002179652A (ja) 2002-06-26
EP1050531A1 (fr) 2000-11-08
PL197661B1 (pl) 2008-04-30
JP2000355579A (ja) 2000-12-26
DK1050531T3 (da) 2005-03-21
AU764388B2 (en) 2003-08-14
KR20010020808A (ko) 2001-03-15
US20030139408A1 (en) 2003-07-24
ZA200002207B (en) 2000-11-14
HU0001789D0 (en) 2000-07-28
CN100371326C (zh) 2008-02-27
HUP0001789A2 (en) 2001-03-28
US6511992B2 (en) 2003-01-28
NO317095B1 (no) 2004-08-09
EA200000389A2 (ru) 2000-12-25
MXPA00004343A (es) 2002-03-08
US20020035123A1 (en) 2002-03-21
KR100472519B1 (ko) 2005-03-07
JP3533361B2 (ja) 2004-05-31
PL339994A1 (en) 2000-11-06
NZ504338A (en) 2001-06-29
DE60015844D1 (de) 2004-12-23
PT1050531E (pt) 2005-03-31
EP1050531B1 (fr) 2004-11-17
NO20002351D0 (no) 2000-05-04
DE60015844T2 (de) 2005-10-27
US6638946B2 (en) 2003-10-28
HUP0001789A3 (en) 2004-04-28
US20050004168A1 (en) 2005-01-06
CA2308867C (fr) 2006-03-14
BR0002287A (pt) 2001-01-02
CA2308867A1 (fr) 2000-11-05

Similar Documents

Publication Publication Date Title
NO20005715D0 (no) Nye substituerte cykliske forbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
DE69501947D1 (de) SUBSTITUIERTE AROMATISCHE VERBINDUNGEN ALS c. AMP PHOSPHODIESTERASE-UND TNF-HEMMER
HUP9701157A2 (hu) Heterociklusos kondenzált piridinszármazékok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények
EP0970954A4 (en) 3-PIPERIDYL-4-OXOCHINAZOLINE DERIVATIVES AND MEDICAL COMPOSITIONS CONTAINING THEM
NZ240676A (en) Heterocyclic compounds substituted by a (piperidin-4-yl)-1-oxoalkyl group and pharmaceutical compositions thereof
NO20022558L (no) 4-karboksyamino-2-etyl-1,2,3,4-tetrahydrokinolinkrystall som CETP inhibitor
MEP9309A (en) Novel oligosaccharides, preparation method and pharmaceutical compositions containing the same
ATE302778T1 (de) N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE103812T1 (de) Zusammensetzung zur behandlung von ischaemischen stoerungen in organen.
NO984740L (no) Isatinderivater som acetylcholinesteraseinhibitorer og analgetiske midler
EA200000389A3 (ru) Новые замещенные пиридины или пиперидины, способ их получения и содержащие их фармацевтические композиции
SE9903894D0 (sv) Novel compounds
FR2803593B1 (fr) Nouvelles tetrahydropyridines, procede pour leur preparation et compositions pharmaceutiques les contenant
EE03296B1 (et) Hüdroksiimhappe derivaadid, neid sisaldavad ravimsegud ja nende valmistamise protsess
DE69710909D1 (de) Substituierte tetrahydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
GEP20032928B (en) Halo Derivatives of 9-Deoxo-9a-Aza-9a-Homerythromycin A, Method for its Production, Pharmaceutical Compositions Containing the Same and Their Use for Treatment or Prevention of Bacterial Infections
NO904135L (no) Fremgangsmaate for fremstilling av nye substituerte alkylpiperidiner og deres anvendelse som inhibitorer av kolesterolsyntese.
EA199900156A1 (ru) Новые производные эритромицина, способ их получения и их применение в качестве медикаментов
IT8621999A1 (it) Derivati pirido-benzotiazinici ad attività antibatterica ed a lunga durata di azione
EA200000261A3 (ru) Новые замещенные димерные соединения, способ их получения и содержащияся их фармацевтическая композиция
FR2683221B1 (fr) Nouveaux derives de cinnolinones-4, leur preparation et leur application en therapeutique.
NO20010801L (no) Nye 6-amino- eller 6-hydroazino-sulfonyl-3- kinolynylfosfonsyreforbindelse, fremgangsmåte ved deresfremstilling og farmasöytiske sammensetninger inneholdende dem
FR2823749B1 (fr) Phenyl- et pyridyl-piperidines, procede pour leur preparation et compositions pharmaceutiques les contenant
EP0380669A4 (en) Isoprenoid derivatives and pharmaceutical preparation containing same
EE200200302A (et) Küllastumata 14,15-tsüklopropanoandrostaanid, nende valmistamise meetod ja neid ühendeid sisaldavadfarmatseutilised kompositsioonid

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU